Elisabeth I. Heath

Wayne State University School of Medicine
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (106)

A and B. Evaluation of Vβ repertoire. The three distinct patterns were observed for Vβ repertoire in CD3+/IFN-γ+ T cells post IT. Pattern 1) the proportions of Vβ repertoire noticeably higher after IT relative to preIT PBMC (solid black arrows); Pattern 2) the proportions of Vβ repertoire that were marginally higher at mid- and/or post-IT relative to pre-IT PBMC (dashed black arrows); Pattern 3) large proportions of Vβ repertoire were either lower or similar at mid-IT or post-IT relative to preIT PBMC in all four patients tested. PreIT (pretherapy), midIT (preinfusion 5) postIT (1 week post infusion 8 of BATs).

Year:

2025

A-C. FFPE sections of PC were stained by multiplex staining panel for CD4, CD8, FoxP3 (T regulatory cells), CD19 (B cells), CD68 (macrophages). Stained sections were imaged on the Hamamatsu slide scanner NanoZoomer S360 and images were viewed on the NDP viewer software. Analysis of images were performed on online Visiopharm software. Using the low power image, high-powered Fields (HPFs) were selected from specific tumor regions. Data shows the distribution of CD4+ (teal), CD8+ (purple), FoxP3 (brown), CD19+ (green) and CD68+ (yellow) cells on two representative whole scanned slide images (KCI 04 and KCI 11) are shown. Top panel shows whole scanned tumor sections, inset 1 and 2 are shown below at high magnification (40x). B and C) Show the second set of serial sections of tumor specimens stained for IFN-γ and IL-10 from two patients shown in the upper panel, both IFN-γ (brown) and IL-10 (brown) were stained individually.

Year:

2025

Comparison of the frequencies of additional molecular features between non-castrate (NC) and castrate (C) samples in ATMm, BRCA2m, HRDother, and HRP groups. The significant differences between the two groups are highlighted (red box).

Year:

2025

The roles of nucleoplasm-residing nucleoporins (NUP) in solid tumors, including prostate cancer, remain unknown. In this study, we reveal the clinical significance and mechanistic role of the off-pore NUP, soluble POM121 (sPOM121), as a crucial transcriptional regulator that enhances the aggressiveness of metastatic prostate cancer. Using orthogonal methodologies in human samples, sPOM121 was identified as the predominantly expressed nucleoplasmic NUP in prostate cancer. Unbiased proteomic and epigenomic studies demonstrate that sPOM121, through its C-terminus, interacts with the chromatin remodeler SMARCA5 at gene promoter sites and localizes at nuclear condensates, reprogramming gene expression. Indeed, sPOM121 regulates a distinct oncogenic gene network, including β-catenin, leading to prostate cancer progression and immune evasion. Importantly, targeting the sPOM121/β-catenin axis in patient-derived preclinical and syngeneic mouse models halts prostate cancer aggressiveness and enhances antitumor immunity. Taken together, these findings reveal previously unknown actionable reprogramming functions of off-pore NUPs in solid tumors. Significance: This study uncovers how oncogenic signaling programs are transcriptionally heightened by the NUP sPOM121 in metastatic prostate cancer. Localization of sPOM121 at active transcriptional nuclear condensates propels disease progression and immune evasion, offering novel anticancer therapeutic opportunities.

Year:

2025

Supplemental Table 1 shows specimens by cancer type; Supplemental Figure 1 shows CH variants by patient age; Supplemental Figure 2 shows variant classification by gDNA and plasma variant frequency for gDNA VF ≤ 0.20

Year:

2025

Purpose: Plasma-based liquid biopsy tests can detect tumor-specific genetic alterations and offer many advantages that complement tissue-based comprehensive genomic profiling. However, age-related clonal hematopoiesis (CH) mutations can confound liquid biopsy results and potentially lead to incorrect therapy choice. Experimental Design: We assessed the landscape of 16,812 liquid profiles across 49 cancer types using the Caris Assure assay, a whole-exome and whole-transcriptome next-generation sequencing workflow that independently sequences both plasma-derived cell-free total nucleic acids and the white blood cell DNA and RNA from the buffy coat. The variant source was identified algorithmically by comparing plasma and buffy coat variant frequency and read quality metrics. Results: Of 16,812 patients, 42.3% presented at least one CH variant among reportable clinical genes. We found 39% of BRCA2 variants to be of CH origin, as well as 37.9% of CHEK2 , 27.4% of BRCA1 , 20.1% of ATM , 7.3% of NRAS , 5.8% of BRAF , 2.1% of EGFR , 2.1% of KRAS , and 18.5% of TP53 . For patients aged 65 to 69 years, the median proportion of CH variant classification was 20%, whereas it was 33% for patients aged 70 to 74 years, 33% for ages 75 to 79 years, and 50% for ages 80+ years. We found high rates of CH detected in what would be otherwise druggable targets in many cancer types typically treated with PARP inhibitors, including breast, female genital tract, ovarian, pancreatic, prostate, and endometrial cancers. Conclusions: This large study highlights the need for thorough CH classification during liquid biopsy to appropriately recommend therapies, especially PARP inhibitors. See related commentary by Bernard and Micol, p. 2545

Year:

2025

Supplementary Figure S3: Immune repertoire of DLL3-high versus –low NENs across anatomic sites. Stacked radar plots comparing the imputed cell fractions of immune cells between DLL3-high and -low samples in (A) lung NECs, (B) lung NETs, (C) prostate NENs, and (D) bladder NENs. *q

Year:

2025

Supplementary Figure S2: Correlations between expression of DLL3, ASCL1, and NEUROD1 across select NEN sites. Scatterplots displaying the expression of DLL3 vs ASCL1 (top) and DLL3 vs NEUROD1 (bottom) across NEN sites. Expression is depicted as log(TPM + 0.001). Spearman correlations and corresponding p-values are shown for each site.

Year:

2025

Supplementary Figure S1: UMAP view of NEN samples across diverse anatomic sites. Samples were unbiasedly clustered based off the top 1,000 variably expressed genes across samples and annotated using (A) DLL3 expression level and (B) anatomic site of origin.

Year:

2025

Supplementary Figure S4: Genetic dependencies in neuroendocrine cancer cell lines. Scatterplot displaying gene depletion effects in NEN lines represented in DepMap. Data points represent the mean gene depletion effect of each gene target. Highlighted genes represent potential dependencies (gene effect

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (103)

Greg Dyson

Professor

Wayne State University

UNITED STATES
View details

Aditya Bagrodia

University of Texas Southwestern

UNITED STATES
View details

Andrew Armstrong

Professor

Duke Cancer Institute

UNITED STATES
View details

Yong Tae Kwon

Professor

Seoul National University

SOUTH KOREA
View details

Ulka Vaishampayan

Professor

University of Michigan

UNITED STATES
View details

Oliver Sartor

Tulane University School of Medicine

UNITED STATES
View details

Guru P. Sonpavde

University of Central Florida

UNITED STATES
View details

Ginger Milne

Professor with Tenure

Vanderbilt University Medical Center

UNITED STATES
View details

Pedro Barata

Associate Professor of Medicine

University Hospitals Seidman Cancer Center

UNITED STATES
View details

John Lozada

University of Rochester Medical Center

UNITED STATES
View details

Benedito A. Carneiro

-

UNITED STATES
View details

George Sledge

-

UNITED STATES
View details

Grace Blitzer

University of Wisconsin-Madison

UNITED STATES
View details

Frank Cackowski

Assistant Professor

Karmanos Cancer Institute

UNITED STATES
View details

Samuel Kareff

University of Miami School of Medicine

UNITED STATES
View details

Phillip Palmbos

Assistant Professor

University of Michigan Hospital

UNITED STATES
View details

Hirva Mamdani

Karmanos Cancer Institute

UNITED STATES
View details

Michael Brown

Assistant Professor

Duke University

UNITED STATES
View details

Channing Paller

Johns Hopkins University

UNITED STATES
View details

Joshua Lang

Professor

University of Wisconsin-Madison

UNITED STATES
View details

Natalie Reizine

Assistant Professor

University of Chicago

UNITED STATES
View details

Arul M Chinnaiyan

University of Michigan

UNITED STATES
View details

Akhilesh Kumar

Faculty, Assistant Professor

University of Minnesota

UNITED STATES
View details

Scott Tagawa

Weill Cornell Medicine

UNITED STATES
View details

Emil Lou

University of Minnesota

UNITED STATES
View details

Julie Boerner

Associate Professor

Wayne State University

UNITED STATES
View details

Ari VanderWalde

Global Head of Clinical Trials

-

UNITED STATES
View details

Young Whang

University of North Carolina at Chapel Hill School of Medicine

UNITED STATES
View details

Mohammed Al Hallak

Assistant Professor

Wayne State University School of Medicine

UNITED STATES
View details

Eugene Shenderov

Associate Professor

Johns Hopkins University School of Medicine

UNITED STATES
View details

Kent Mouw

Assistant Professor

Dana-Farber Cancer Institute

UNITED STATES
View details

HAMID EMAMEKHOO

University of Wisconsin-Madison

UNITED STATES
View details

Justin E. Wilson

Associate Professor

-

UNITED STATES
View details

Haojie Huang

Professor

Mayo Clinic College of Medicine and Science

UNITED STATES
View details

Alicia Morgans

Dana-Farber Cancer Institute

UNITED STATES
View details

Steven Kregel

Assistant Professor

Loyola University Chicago

UNITED STATES
View details

Hyeong‐Reh C. Kim

Vice Dean of Research

Wayne State University

UNITED STATES
View details

Justin Hwang

Associate Professor

University of Minnesota

UNITED STATES
View details

Shuang G. Zhao

University of Wisconsin-Madison

UNITED STATES
View details

Terry Hyslop

Professor, Director of SKCCC Center for Cancer Health Equity

Thomas Jefferson University

UNITED STATES
View details

Kim Chi

Chief Medical Officer

BC Cancer

CANADA
View details

Veronica Rodriguez-Bravo

Associate Professor

Mayo Clinic

UNITED STATES
View details

Shijia Zhu

Assistant Professor

University of Minnesota

UNITED STATES
View details

Catherine Marshall

Associate Professor

Johns Hopkins University School of Medicine

UNITED STATES
View details

Jinhua Wang

professor

University of Minnesota System

UNITED STATES
View details

Wei Chen

Professor

Wayne State University

UNITED STATES
View details

Lawrence G. Lum

Professor of Medicine

University of Virginia

UNITED STATES
View details

Rohan Garje

Clinical Associate professor

Iowa State University

UNITED STATES
View details

Daniel J. George

Professor

Duke University

UNITED STATES
View details

Ira Winer

Professor

Wayne State University

UNITED STATES
View details

David Hsiehchen

University of Texas Southwestern Medical Center

UNITED STATES
View details

Frank Cichocki

Assistant Professor

University of Minnesota

UNITED STATES
View details

Heloisa Soares

Associate Professor

Huntsman Cancer Institute

UNITED STATES
View details

David Kosoff

University of Wisconsin-Madison

UNITED STATES
View details

Noel Warfel

Associate Professor

Medical University of South Carolina

UNITED STATES
View details

Emily Egusa

University of California, San Francisco

UNITED STATES
View details

Josep Domingo-Domenech

Professor

Mayo Clinic

UNITED STATES
View details

Heather H. Cheng

Professor

University of Washington

UNITED STATES
View details

Menggang Yu

Professor

University of Michigan

UNITED STATES
View details

Joaquin Mateo

Group Leader

Vall d´Hebron Institute of Oncology

SPAIN
View details

Leonard Appleman

Associate Professor

University of Pittsburgh

UNITED STATES
View details

Haidong Dong

Professor/Consultant

Mayo Clinic Rochester

UNITED STATES
View details

Jacob Orme

Assistant Professor

Mayo Clinic

UNITED STATES
View details

Scott M Dehm

Faculty, Professor

University of Minnesota

UNITED STATES
View details

Abdo Najy

Assistant Professor-Research

Wayne State University

UNITED STATES
View details

Evan Y. Yu

University of Washington

UNITED STATES
View details

Marina N Sharifi

Assistant Professor

University of Wisconsin-Madison

UNITED STATES
View details

Karen S Sfanos

Johns Hopkins University School of Medicine

UNITED STATES
View details

Christopher J. Hoimes

Duke University

UNITED STATES
View details

Anders Bjartell

Lund University

SWEDEN
View details

Anne Cress

Professor

University of Arizona

UNITED STATES
View details

Emmanuel S. Antonarakis

-

UNITED STATES
View details

Michael Carducci

Vice Chair, Solid Tumor Oncology

Johns Hopkins University

UNITED STATES
View details

Carly Miller

University of Minnesota

UNITED STATES
View details

Jonathan Chou

Assistant Professor

University of California, San Francisco

UNITED STATES
View details

Jeffrey S Miller

University of Minnesota System

UNITED STATES
View details

Felix Y. Feng

University of California

UNITED STATES
View details

Mukesh Pandey

Professor of Radiology

Mayo Clinic

UNITED STATES
View details

Atish Choudhury

Dana-Farber Cancer Institute

UNITED STATES
View details

Archana Thakur

Associate Professor

University of Virginia

UNITED STATES
View details

Kevin Kelly

Professor, Associate Director of Research, SKCC

Thomas Jefferson University

UNITED STATES
View details

Shailender Singh Chauhan

Staff Scientist II

Medical University of South Carolina

UNITED STATES
View details

Seongho Kim

Professor of Biostatistics

Wayne State University School of Medicine

UNITED STATES
View details

Charles Nguyen

Assistant Clinical Professor

City Of Hope National Medical Center

UNITED STATES
View details

Megan E.V. Caram

University of Michigan

UNITED STATES
View details

Peter S. Nelson

Fred Hutchinson Cancer Research Center

UNITED STATES
View details

Brent Rose

Associate Professor

UC San Diego Health System

UNITED STATES
View details

Russell K. Pachynski

Washington University School of Medicine

UNITED STATES
View details

Kathleen Storey

Assistant Professor

University of Minnesota

UNITED STATES
View details

Nicholas Zorko

Assistant Professor

University of Minnesota

UNITED STATES
View details

Neeraj Agarwal

Faculty Member

Dana-Farber Cancer Institute

UNITED STATES
View details

Daniel P. Petrylak

-

UNITED STATES
View details

Travis Wheeler

Professor

University of Arizona

UNITED STATES
View details

Rana R. McKay

University of California, San Diego

UNITED STATES
View details

Samuel R. Denmeade

-

UNITED STATES
View details

Michael Gunn

Professor

Duke University

UNITED STATES
View details

Dave Hoon

Principal Investigator

The Lundquist Institute

UNITED STATES
View details

Yeon Sung Son

Research Professor

Seoul National University

SOUTH KOREA
View details

Xiaolei Shi

Assistant professor

University of Maryland Medical Center

UNITED STATES
View details

Amy Schienschang

University of Virginia

UNITED STATES
View details

Veerabhadran Baladandayuthapani

Jeremy M.G. Taylor Collegiate Professor of Biostatistics and Chair of Department of Biostatistics

University of Michigan

UNITED STATES
View details

Sebastien Hotte

McMaster University

CANADA
View details

Gilberto Lopes

Associate Professor

Sylvester Comprehensive Cancer Center

UNITED STATES
View details